Name: Saluda Medical (SLD) Short Position History
Creator: Shorted
License: https://creativecommons.org/licenses/by/4.0/

SLD

Health Care Equipment & Services

Saluda Medical

Short interest: 0.08%; −0.05 pp 30d; as of 8 Oct 2026
Reported shorts: 212.8K
Shares on issue: 252.024M

Price & short interest

Toggle series, zoom, and compare · ASIC daily, T+4

About Saluda Medical

Saluda Medical, Inc. is a medical technology company focused on developing and commercializing innovative solutions for patients suffering from chronic pain. Their primary focus is on neurostimulation therapies, aiming to provide more effective and personalized pain relief. Saluda's technology seeks to disrupt the pain management market by removing guesswork and tailoring treatment to individual patient needs.

Company profile →

Saluda Medical (ASX:SLD) has 0.08% of its shares on issue reported as short positions as of 8 Oct 2026, or about 212,758 shares. Over the past 30 days that figure has been broadly flat, and over 90 days it has been broadly flat. SLD is classified in the Health Care Equipment & Services industry. All figures come from official ASIC short position reports, published with a four trading-day (T+4) delay.

Short interest

History & FAQ →

Weekly context: The 10 most shorted ASX stocks — Week 41, 2026.

Strategy fit

How each stock picker strategy reads SLD today

Zanger BreakoutWatchScore 15rank 1484 of 1942
CAN SLIMWatchScore 7rank 1465 of 1541
Minervini Trend TemplateNot a candidate
Crowded-Short BreakoutNot a candidate
Quality compoundersWatchScore 10rank 1290 of 1669

Prices to 14 Oct 2026 · Mechanical readings of published rules, not recommendations · Not financial adviceFull strategy readings →

SLD fundamentals

In the year to 30 Jun 2026, Saluda Medical (ASX:SLD) recorded revenue of US$90.2M and a net loss after tax of US$149.6M. A year earlier it recorded revenue of US$70.4M and a net loss after tax of US$149.3M. Year-on-year growth: revenue +28.2% (FY). Net margin −165.9% (FY). Figures are in USD, the company's reporting currency; source: ASX (Markit), as at 14 Oct 2026.

Full statements, ratios and filings are on the Financials tab. Not financial advice.

Full financials →